Compare ADUS & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADUS | OMCL |
|---|---|---|
| Founded | 1979 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2009 | 2000 |
| Metric | ADUS | OMCL |
|---|---|---|
| Price | $98.97 | $42.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $133.78 | $55.83 |
| AVG Volume (30 Days) | 208.0K | ★ 503.5K |
| Earning Date | 05-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.40 | N/A |
| EPS | ★ 5.22 | 0.04 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | $9.17 | $6.77 |
| Revenue Next Year | $4.70 | $5.22 |
| P/E Ratio | ★ $18.51 | $1,035.13 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $90.89 | $22.66 |
| 52 Week High | $124.44 | $51.84 |
| Indicator | ADUS | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 57.85 | 63.50 |
| Support Level | $91.33 | $30.52 |
| Resistance Level | $118.93 | $46.29 |
| Average True Range (ATR) | 2.43 | 2.05 |
| MACD | 0.93 | 0.79 |
| Stochastic Oscillator | 95.71 | 65.21 |
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.